March 3, 2026

Aalo Secures Fuel Fabrication Contract with Global Nuclear Fuel ()

Aalo Atomics has signed a fuel fabrication contract with Global Nuclear Fuel, a GE Vernova-led alliance with Hitachi, to supply low-enriched uranium fuel rods for the Aalo-X reactor ahead of its targeted 2026 criticality at Idaho National Laboratory...

March 2, 2026

SHINE Raises $240M to Scale Nuclear Medicine Platform and Expand Lu-177 Production ()

SHINE Technologies has raised $240M to expand its nuclear medicine operations, including large-scale production of Lutetium-177 used in targeted cancer therapies, following its recent acquisition of Lantheus’ SPECT business...

February 25, 2026

DOE Reactor Pilot Program Advances Toward July 2026 Criticality Target ()

Portfolio companies, Radiant Nuclear and Aalo Atomics, are among a select group of reactor developers that are progressing under DOE’s accelerated Reactor Pilot Program, targeting criticality by July 4, 2026, through streamlined federal authorization pathways.

February 23, 2026

Copenhagen Atomics Signs Thorium Supply LoI with Rare Earths Norway ()

Copenhagen Atomics signed a Letter of Intent with Rare Earths Norway to secure future access to thorium from Norway’s Fensfeltet deposit to support long-term fuel supply planning ahead of commercial deployment...

February 21, 2026

SHINE Signs Lu-177 Supply LoI with Swedish Biotech Affibody ()

SHINE Technologies signed a Letter of Intent with Swedish biotech Affibody AB to supply non-carrier-added Lutetium-177 for clinical development of its radioligand therapy pipeline, including Phase 1 candidate ABY-271, with potential commercial supply to be explored if the program advances...

February 18, 2026

Radiant Adds Lockheed Martin as Strategic Investor in Oversubscribed Round ()

In an already oversubscribed Series D round, Radiant has added Lockheed Martin as a strategic investor, reinforcing defense-sector alignment ahead of first reactor startup and commercialization of its Kaleidos microreactor...

February 18, 2026

Deep Isolation Appoints Joseph Nelson as CFO as Company Prepares for Public Listing ()

Deep Isolation appointed Joseph Nelson as Chief Financial Officer, bringing public company and capital markets experience as the company advances its full-scale demonstration program and prepares for public listing.

February 13, 2026

Norway Initiates Formal Impact Assessment for Proposed SMR Plant ()

Norsk Kjernekraft, a collaborative partner to Blykalla, recently secured approval from Norwegian authorities to start an impact assessment for a proposed multi-SMR plant in Aure and Heim, initiating the first step in the country’s nuclear licensing process...

February 12, 2026

Focused Energy’s Biblis Fusion Strategy Gains Industry Spotlight ()

Focused Energy’s plan to transform Germany’s decommissioned Biblis nuclear plant into a fusion engineering campus and prototype power site was featured in industry coverage, highlighting brownfield reuse, regulatory reform, and utility partnership as pillars of the strategy...

February 12, 2026

Copenhagen Atomics Achieves Two-Year Continuous Molten Salt Pump Operation ()

Portfolio company, Copenhagen Atomics, has completed two years of continuous high-temperature molten salt pump operation, surpassing 100,000 combined pump runtime hours across its test infrastructure and generating durability data critical for molten salt reactor deployment...

© 2026 Nucleation Capital | Terms & Policies

linkedin, for social media footer
X-logo, for social media footer
Nucleation transparent